急性创伤性脑损伤患者入院时全血转录组特征揭示中性粒细胞为主的系统性免疫反应
单中心前瞻性观察研究对42例急性TBI患者和21例健康对照的入院全血行RNA测序,差异表达分析发现996个上调、863个下调基因,中性粒细胞脱颗粒、NET信号通路和TLR信号通路上调,上游调控因子包括TNF、IL1B、IFNG、STAT3;去卷积显示髓系分数相对升高、淋系相对降低;中性粒细胞脱颗粒特征评分与损伤严重度评分(ISS)相关(Spearman ρ=+0.55,q<0.001)。该反应在无严重颅外损伤患者中也可见,但因缺乏匹配的非TBI创伤对照,不能确立TBI特异性分子签名或机制。
要点
- 急性TBI患者入院全血转录组以中性粒细胞相关基因(DUSP1、HMGB2、MMP9、S100A8)上调为特征,伴中性粒细胞脱颗粒和NET信号通路上调。
- 去卷积分析显示TBI患者髓系细胞分数相对升高、淋系细胞分数相对降低(22个免疫亚群中7个有差异,q<0.05)。
- 中性粒细胞脱颗粒特征评分与总ISS相关(Spearman ρ=+0.55,q<0.001),提示该转录反应与整体损伤严重度相关。
- 该中性粒细胞为主的反应在无严重颅外损伤的TBI患者中同样可见,但研究缺乏匹配的非TBI创伤对照,不能认定为TBI特异性签名。
适用人群与场景
- 单中心前瞻性观察研究纳入的42例急性TBI患者(入院时采集全血),对照为21例健康人;原文未明确列出TBI纳入标准和排除标准。
- 原文未提及该转录组特征在急诊/ICU/院前具体场景或病情阶段的适用条件。
诊断标准与关键阈值
- 原文未提及诊断标准或关键阈值;差异表达分析采用limma-voom,阈值FDR<0.05且|log2FC|>0.7。
- 去卷积差异免疫亚群判定阈值为q<0.05;中性粒细胞脱颗粒特征评分与ISS相关性采用Spearman ρ及q<0.001。
处置流程与药物剂量
- 原文未提及基于该转录组特征的具体处置流程或药物剂量。
红旗征与不能漏的情况
- 原文未提及红旗征或需要立刻处理的情况。
研究设计与关键结果
- 单中心前瞻性观察研究,42例急性TBI患者与21例健康对照,入院全血RNA测序;差异表达分析发现996个上调基因和863个下调基因(FDR<0.05,|log2FC|>0.7)。
- 上调基因包括炎症、先天免疫和中性粒细胞相关基因DUSP1、HMGB2、MMP9、S100A8;IPA通路中中性粒细胞脱颗粒、中性粒细胞胞外诱捕网信号通路和Toll样受体信号通路z评分为正。
- 上游调控因子包括TNF、IL1B、IFNG和STAT3;CIBERSORTx LM22去卷积显示22个免疫亚群中7个有差异(q<0.05),TBI组髓系分数相对较高、淋系分数相对较低。
- 中性粒细胞脱颗粒特征评分与TBI患者总ISS相关(Spearman ρ=+0.55,q<0.001);该反应在无严重颅外损伤的患者中也可见。
证据类型、等级与局限
- 证据类型:单中心前瞻性观察研究(论文);原文未给出证据等级或推荐强度。
- 局限:缺乏匹配的非TBI创伤对照,不能确立TBI特异性分子签名或机制;原文将其定位为描述性特征。
对床旁实践的改变
- 该研究提示急性TBI入院时即存在中性粒细胞为主的系统性转录反应并与总ISS相关,但为描述性研究,尚不能据此改变急诊/ICU的常规诊疗决策。
- 适用与不适用人群:研究仅纳入急性TBI患者与健康对照,缺乏非TBI创伤对照,不能将所见转录特征用于鉴别TBI与非TBI创伤或作为TBI特异性诊断依据。
- 常见陷阱:不能将中性粒细胞脱颗粒特征评分与ISS的相关性(ρ=+0.55)当作临床决策阈值或预后判断工具。
指南或共识出处
- 原文未提及
以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Acute traumatic brain injury (TBI) is accompanied by systemic immune responses, but their whole-blood transcriptomic features at hospital arrival remain incompletely characterized. We aimed to characterize these features in patients with acute TBI compared with healthy controls.
METHODS: In this single-center prospective observational study, we performed whole-blood RNA sequencing on hospital-arrival samples from 42 patients with acute TBI and 21 healthy controls. Analyses included differential expression (limma-voom; FDR < 0.05, |log2FC| > 0.7), functional enrichment, Ingenuity Pathway Analysis, CIBERSORTx LM22 deconvolution, and per-sample neutrophil degranulation signature scoring.
RESULTS: Differential expression analysis identified 996 upregulated and 863 downregulated genes, with marked upregulation of inflammation-, innate immunity-, and neutrophil-related genes including DUSP1 , HMGB2 , MMP9 , and S100A8 . Canonical pathways with positive IPA z-scores included Neutrophil degranulation, Neutrophil Extracellular Trap Signaling Pathway, and Toll-like Receptor Signaling; upstream regulators included TNF , IL1B , IFNG , and STAT3 . Deconvolution identified 7 of 22 differing subsets ( q < 0.05), with relatively higher myeloid and lower lymphoid fractions in TBI. The Neutrophil degranulation signature score correlated with Injury Severity Score within TBI (Spearman ρ = +0.55; q < 0.001 ).
CONCLUSIONS: Admission whole-blood transcriptomics characterized a neutrophil-predominant systemic transcriptional response in patients with acute TBI. This response was also evident among patients without major extracranial injury and was associated with total ISS. However, because the study lacked an appropriately matched non-TBI trauma comparator, the findings should be interpreted as a descriptive characterization of a systemic injury response accompanying TBI and do not establish a TBI-specific molecular signature or mechanism.
参考来源
- Nishida T, Nakamura Y, Matsumoto H, et al. Admission whole-blood transcriptomic characterization of a neutrophil-predominant systemic immune response in patients with acute traumatic brain injury. Shock. 2026. PMID: 42735045. doi:10.1097/SHK.0000000000002939
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。